{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:19:46Z","timestamp":1792131586718,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77664-4","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T06:02:42Z","timestamp":1730527362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy"],"prefix":"10.1038","volume":"14","author":[{"given":"Muhammad","family":"Naveed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbakht","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muzzammel","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metab","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah F","family":"Alasmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"issue":"10074","key":"77664_CR1","first-page":"1134","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck, N. & Gnant, M. Breast cancer Lancet, 389(10074): 1134\u20131150. (2017).","journal-title":"Breast cancer Lancet"},{"key":"77664_CR2","doi-asserted-by":"publisher","first-page":"107327482412706","DOI":"10.1177\/10732748241270628","volume":"31","author":"Z Ma","year":"2024","unstructured":"Ma, Z. et al. Establishment of Prognostic Nomogram for male breast Cancer patients: a surveillance, epidemiology and end results database analysis. Cancer Control. 31, 10732748241270628 (2024).","journal-title":"Cancer Control"},{"key":"77664_CR3","unstructured":"Breast Cancer Treatment (PDQ)."},{"key":"77664_CR4","doi-asserted-by":"publisher","first-page":"153303382412618","DOI":"10.1177\/15330338241261836","volume":"23","author":"A Chidambaram","year":"2024","unstructured":"Chidambaram, A. et al. Male breast Cancer: current scenario and future perspectives. Technol. Cancer Res. Treat. 23, 15330338241261836 (2024).","journal-title":"Technol. Cancer Res. Treat."},{"key":"77664_CR5","unstructured":"Saunders, C. & Jassal, S. Breast Cancer (OUP Oxford, 2009)."},{"key":"77664_CR6","doi-asserted-by":"publisher","first-page":"9605439","DOI":"10.1155\/2022\/9605439","volume":"2022","author":"D Kashyap","year":"2022","unstructured":"Kashyap, D. et al. Global increase in breast Cancer incidence: risk factors and preventive measures. Biomed. Res. Int. 2022, 9605439 (2022).","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"77664_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djy106","volume":"110","author":"H Shimelis","year":"2018","unstructured":"Shimelis, H. et al. Triple-negative breast Cancer risk genes identified by Multigene Hereditary Cancer Panel Testing. J. Natl. Cancer Inst. 110(8), 855\u2013862 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"77664_CR8","unstructured":"Genetics of Breast and Gynecologic Cancers (PDQ(R)): Health Professional Version, in PDQ Cancer Information Summaries. : Bethesda (MD). (2002)."},{"issue":"8","key":"77664_CR9","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1002\/ijc.32547","volume":"146","author":"JJ Lo","year":"2020","unstructured":"Lo, J. J. et al. Association between meat consumption and risk of breast cancer: findings from the Sister Study. Int. J. Cancer. 146(8), 2156\u20132165 (2020).","journal-title":"Int. J. Cancer"},{"issue":"Suppl 1","key":"77664_CR10","doi-asserted-by":"publisher","first-page":"9s","DOI":"10.2967\/jnumed.115.157834","volume":"57","author":"ES McDonald","year":"2016","unstructured":"McDonald, E. S. et al. Clinical diagnosis and management of breast Cancer. J. Nucl. Med. 57 (Suppl 1), 9s\u201316s (2016).","journal-title":"J. Nucl. Med."},{"issue":"4","key":"77664_CR11","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S1470-2045(18)30094-9","volume":"19","author":"SN Weingart","year":"2018","unstructured":"Weingart, S. N. et al. Chemotherapy medication errors. Lancet Oncol. 19(4), e191\u2013e199 (2018).","journal-title":"Lancet Oncol."},{"issue":"8","key":"77664_CR12","first-page":"1218","volume":"47","author":"I Altun","year":"2018","unstructured":"Altun, I. & Sonkaya, A. The most common side effects experienced by patients were receiving first cycle of Chemotherapy. Iran. J. Public. Health. 47(8), 1218\u20131219 (2018).","journal-title":"Iran. J. Public. Health"},{"issue":"1","key":"77664_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00066-015-0899-y","volume":"192","author":"U Hille-Betz","year":"2016","unstructured":"Hille-Betz, U. et al. Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy: risk-modifying factors. Strahlenther Onkol. 192(1), 8\u201316 (2016).","journal-title":"Strahlenther Onkol"},{"key":"77664_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-016-0158-5","volume":"4","author":"H Rehman","year":"2016","unstructured":"Rehman, H. et al. Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy. J. Immunother Cancer. 4, 53 (2016).","journal-title":"J. Immunother Cancer"},{"issue":"7","key":"77664_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","volume":"30","author":"SJ Russell","year":"2012","unstructured":"Russell, S. J., Peng, K. W. & Bell, J. C. Oncolytic virotherapy. Nat. Biotechnol. 30(7), 658\u2013670 (2012).","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"77664_CR16","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/cas.13027","volume":"107","author":"H Fukuhara","year":"2016","unstructured":"Fukuhara, H., Ino, Y. & Todo, T. Oncolytic virus therapy: a new era of cancer treatment at dawn. Cancer Sci. 107(10), 1373\u20131379 (2016).","journal-title":"Cancer Sci."},{"key":"77664_CR17","doi-asserted-by":"crossref","unstructured":"Matveeva, O. V. & Chumakov, P. M. Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses. Rev Med Virol, 28(6): p. e2008. (2018).","DOI":"10.1002\/rmv.2008"},{"issue":"4","key":"77664_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/2326-6066.CIR-14-0015","volume":"2","author":"EA Chiocca","year":"2014","unstructured":"Chiocca, E. A. & Rabkin, S. D. Oncolytic viruses and their application to cancer immunotherapy. Cancer Immunol. Res. 2(4), 295\u2013300 (2014).","journal-title":"Cancer Immunol. Res."},{"key":"77664_CR19","doi-asserted-by":"crossref","unstructured":"Howells, A. et al. Oncolytic Viruses\u2014Interaction of Virus and Tumor cells in the battle to Eliminate Cancer. Front. Oncol., 7. (2017).","DOI":"10.3389\/fonc.2017.00195"},{"key":"77664_CR20","doi-asserted-by":"crossref","unstructured":"Marelli, G. et al. Oncolytic viral therapy and the Immune System: a double-edged Sword Against Cancer. Front. Immunol., 9. (2018).","DOI":"10.3389\/fimmu.2018.00866"},{"issue":"1","key":"77664_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","volume":"6","author":"T Tang","year":"2021","unstructured":"Tang, T. et al. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal. Transduct. Target. Therapy. 6(1), 72 (2021).","journal-title":"Signal. Transduct. Target. Therapy"},{"issue":"1","key":"77664_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41392-022-00951-x","volume":"7","author":"Y Tian","year":"2022","unstructured":"Tian, Y., Xie, D. & Yang, L. Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. Signal. Transduct. Target. Therapy. 7(1), 117 (2022).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"77664_CR23","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"J Bergelson","year":"1997","unstructured":"Bergelson, J. et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science. 275, 1320\u20131323 (1997).","journal-title":"Science"},{"key":"77664_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10238-005-0076-1","volume":"5","author":"T Martin","year":"2005","unstructured":"Martin, T., Watkins, G. & Jiang, W. The coxsackie-adenovirus receptor has elevated expression in human breast cancer. Clin. Experimental Med. 5, 122\u2013128 (2005).","journal-title":"Clin. Experimental Med."},{"issue":"18","key":"77664_CR25","doi-asserted-by":"publisher","first-page":"E4264","DOI":"10.1073\/pnas.1716900115","volume":"115","author":"A Lenman","year":"2018","unstructured":"Lenman, A. et al. Polysialic acid is a cellular receptor for human adenovirus 52. Proc. Natl. Acad. Sci. 115(18), E4264\u2013E4273 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"77664_CR26","doi-asserted-by":"crossref","unstructured":"Tseha, S. T. Role of adenoviruses in Cancer Therapy. Front. Oncol., 12. (2022).","DOI":"10.3389\/fonc.2022.772659"},{"key":"77664_CR27","doi-asserted-by":"publisher","first-page":"707290","DOI":"10.3389\/fmicb.2021.707290","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. Oncolytic adenovirus: prospects for cancer immunotherapy. Front. Microbiol. 12, 707290 (2021).","journal-title":"Front. Microbiol."},{"issue":"1","key":"77664_CR28","doi-asserted-by":"publisher","first-page":"17336","DOI":"10.1038\/s41598-024-68403-w","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. Optimizing the resveratrol fragments for novel in silico hepatocellular carcinoma de novo drug design. Sci. Rep. 14(1), 17336 (2024).","journal-title":"Sci. Rep."},{"issue":"2","key":"77664_CR29","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.gendis.2021.11.011","volume":"10","author":"M Javanbakht","year":"2023","unstructured":"Javanbakht, M. et al. Oncolytic viruses: a novel treatment strategy for breast cancer. Genes Dis. 10(2), 430\u2013446 (2023).","journal-title":"Genes Dis."},{"issue":"1","key":"77664_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","volume":"8","author":"D Lin","year":"2023","unstructured":"Lin, D., Shen, Y. & Liang, T. Oncolytic virotherapy: basic principles, recent advances and future directions. Signal. Transduct. Target. Therapy. 8(1), 156 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"issue":"15_suppl","key":"77664_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1200\/JCO.2021.39.15_suppl.578","volume":"39","author":"HH Soliman","year":"2021","unstructured":"Soliman, H. H. et al. A phase 2 trial of talimogene laherparepvec (TVEC) in combination with neoadjuvant chemotherapy for the treatment of nonmetastatic triple-negative breast cancer. J. Clin. Oncol. 39(15_suppl), 578\u2013578 (2021).","journal-title":"J. Clin. Oncol."},{"key":"77664_CR32","doi-asserted-by":"crossref","unstructured":"Chowaniec, H. et al. New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy. Front. Immunol., 15. (2024).","DOI":"10.3389\/fimmu.2024.1375433"},{"issue":"15","key":"77664_CR33","first-page":"6972","volume":"27","author":"M Naveed","year":"2023","unstructured":"Naveed, M. et al. Halogens engineering-based design of agonists for boosting expression of frataxin protein in Friedreich\u2019s ataxia. Eur. Rev. Med. Pharmacol. Sci. 27(15), 6972\u20136984 (2023).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"77664_CR34","doi-asserted-by":"crossref","unstructured":"Bahi, M. & Batouche, M. Deep learning for ligand-based virtual screening in drug discovery. in 3rd international conference on pattern analysis and intelligent systems (PAIS). 2018. IEEE. (2018).","DOI":"10.1109\/PAIS.2018.8598488"},{"key":"77664_CR35","doi-asserted-by":"crossref","unstructured":"Kang, S. J. & Kim, J. E. Development of clinically optimized sitagliptin and Dapagliflozin Complex Tablets: Pre-formulation, Formulation, and human bioequivalence studies. Pharmaceutics, 15(4). (2023).","DOI":"10.3390\/pharmaceutics15041246"},{"issue":"9","key":"77664_CR36","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1007\/s12325-021-01883-8","volume":"38","author":"GA McComsey","year":"2021","unstructured":"McComsey, G. A. et al. Real-world adherence to antiretroviral therapy among HIV-1 patients across the United States. Adv. Ther. 38(9), 4961\u20134974 (2021).","journal-title":"Adv. Ther."},{"key":"77664_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-1-4939-7201-2_18","volume":"1647","author":"M Kontoyianni","year":"2017","unstructured":"Kontoyianni, M. Docking and virtual screening in Drug Discovery. Methods Mol. Biol. 1647, 255\u2013266 (2017).","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"77664_CR38","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1074\/jbc.M210019200","volume":"278","author":"RS Williams","year":"2003","unstructured":"Williams, R. S. & Glover, J. N. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation. J. Biol. Chem. 278(4), 2630\u20132635 (2003).","journal-title":"J. Biol. Chem."},{"issue":"18","key":"77664_CR39","doi-asserted-by":"publisher","first-page":"E4264","DOI":"10.1073\/pnas.1716900115","volume":"115","author":"A Lenman","year":"2018","unstructured":"Lenman, A. et al. Polysialic acid is a cellular receptor for human adenovirus 52. Proc. Natl. Acad. Sci. U S A. 115(18), E4264\u2013e4273 (2018).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"77664_CR40","doi-asserted-by":"crossref","unstructured":"Rosignoli, S. & Paiardini, A. Boosting the full potential of PyMOL with Structural Biology Plugins. Biomolecules, 12(12). (2022).","DOI":"10.3390\/biom12121764"},{"key":"77664_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/B978-0-12-809633-8.20484-6","volume-title":"Encyclopedia of Bioinformatics and Computational Biology","author":"M Wiltgen","year":"2019","unstructured":"Wiltgen, M. Algorithms for structure comparison and analysis: homology modelling of proteins, in Encyclopedia of Bioinformatics and Computational Biology, (eds Ranganathan, S. et al.) Academic: Oxford. 38\u201361. (2019)."},{"issue":"13","key":"77664_CR42","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1093\/nar\/gkg512","volume":"31","author":"TA Binkowski","year":"2003","unstructured":"Binkowski, T. A., Naghibzadeh, S. & Liang, J. CASTp: computed Atlas of Surface Topography of proteins. Nucleic Acids Res. 31(13), 3352\u20133355 (2003).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"77664_CR43","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1), D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"77664_CR44","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1093\/nar\/gkl412","volume":"34","author":"M van Dijk","year":"2006","unstructured":"van Dijk, M. et al. Information-driven protein-DNA docking using HADDOCK: it is a matter of flexibility. Nucleic Acids Res. 34(11), 3317\u20133325 (2006).","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"77664_CR45","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51(10), 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."},{"issue":"5","key":"77664_CR46","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/bioinformatics\/bts020","volume":"28","author":"D van der Spoel","year":"2012","unstructured":"van der Spoel, D., van Maaren, P. J. & Caleman, C. GROMACS molecule & liquid database. Bioinformatics. 28(5), 752\u2013753 (2012).","journal-title":"Bioinformatics"},{"issue":"5","key":"77664_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10(5), 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov"},{"issue":"W1","key":"77664_CR48","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng, G. et al. HawkDock: a web server to predict and analyze the protein-protein complex based on computational docking and MM\/GBSA. Nucleic Acids Res. 47(W1), W322\u2013w330 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"77664_CR49","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.7150\/ijbs.21635","volume":"13","author":"YS Sun","year":"2017","unstructured":"Sun, Y. S. et al. Risk factors and preventions of breast Cancer. Int. J. Biol. Sci. 13(11), 1387\u20131397 (2017).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"77664_CR50","first-page":"288","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks, A. G. & Winer, E. P. Breast Cancer Treatment: Rev. JAMA, 321(3): 288\u2013300. (2019).","journal-title":"Breast Cancer Treatment: Rev. JAMA"},{"issue":"4","key":"77664_CR51","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/biomedicines9040419","volume":"9","author":"S Chaurasiya","year":"2021","unstructured":"Chaurasiya, S., Fong, Y. & Warner, S. G. Oncolytic Virotherapy for Cancer: clinical experience. Biomedicines. 9(4), 419 (2021).","journal-title":"Biomedicines"},{"issue":"4","key":"77664_CR52","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/v16040567","volume":"16","author":"S Robert","year":"2024","unstructured":"Robert, S. et al. Oncolytic Adenovirus for the targeting of Paclitaxel-resistant breast Cancer stem cells. Viruses. 16(4), 567 (2024).","journal-title":"Viruses"},{"key":"77664_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.virusres.2017.08.016","volume":"240","author":"M Shayestehpour","year":"2017","unstructured":"Shayestehpour, M. et al. Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy. Virus Res. 240, 207\u2013214 (2017).","journal-title":"Virus Res."}],"updated-by":[{"DOI":"10.1038\/s41598-025-97940-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77664-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:03:31Z","timestamp":1744736611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77664-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77664"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77664-4","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-025-97940-1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,2]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-97940-1","URL":"https:\/\/doi.org\/10.1038\/s41598-025-97940-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26405"}}